Reducing Multi-Cycle Reviews Is FDA Priority

Reducing Multi-Cycle Reviews Is FDA Priority
FDA Commissioner Mark McClellan today described key steps the agency is taking to shorten drug approval times, in his keynote speech at IIR�s Phases conference in Washington, D.C.

Click here for reuse options!
Copyright 2003 Biotechblog

Leave a Reply

%d bloggers like this: